Kexing Biopharm Showcases Global Strategy at CPHI Frankfurt 2025 Kexing Biopharm presented its global strategies and partnership opportunities at CPHI Frankfurt 2025, focusing on international market expansion and collaboration.

Kexing Biopharm Showcases Global Strategy at CPHI Frankfurt 2025 #Germany #Frankfurt #Kexing_Biopharm #Global_Strategies #CPHI_Frankfurt

Kexing Biopharm Unveils Global Strategy and Collaboration at CPHI Frankfurt 2025 Kexing Biopharm showcased its global strategy and product offerings at CPHI Frankfurt 2025, engaging in fruitful discussions with industry partners on collaboration.

Kexing Biopharm Unveils Global Strategy and Collaboration at CPHI Frankfurt 2025 #Germany #Frankfurt #global_strategy #Kexing_Biopharm #CPHI

Kexing Biopharm Showcases Global Strategy and Partnerships at CPHI Frankfurt 2025 Kexing Biopharm recently presented its global strategy and partnership opportunities at the influential CPHI Frankfurt 2025 event, focusing on pharmaceuticals.

Kexing Biopharm Showcases Global Strategy and Partnerships at CPHI Frankfurt 2025 #Germany #biopharmaceuticals #Frankfurt #Kexing_Biopharm #CPHI_Frankfurt

Kexing Biopharm Expands Global Strategy at CPHI Frankfurt 2025 Event Kexing Biopharm showcased its innovative strategies at CPHI Frankfurt 2025, highlighting global partnerships and growth opportunities in the pharmaceutical industry.

Kexing Biopharm Expands Global Strategy at CPHI Frankfurt 2025 Event #Germany #biopharmaceuticals #Frankfurt #Kexing_Biopharm #CPHI_2025

BioDlink Successfully Ships Bevacizumab to Colombia, Paving Way for Cancer Treatment Access BioDlink's first international shipment of Bevacizumab injection to Colombia marks a significant advancement in targeted cancer therapy.

BioDlink Successfully Ships Bevacizumab to Colombia, Paving Way for Cancer Treatment Access #Colombia #Kexing_Biopharm #BioDlink #Bevacizumab

Kexing Biopharm Expands Global Presence with Sorafenib Generic Approvals in Egypt and Peru Kexing Biopharm has received approvals for its Sorafenib Tosylate Tablets generic in Egypt and Peru, boosting access to cancer treatment in these regions.

Kexing Biopharm Expands Global Presence with Sorafenib Generic Approvals in Egypt and Peru #China #Shenzhen #Kexing_Biopharm #Sorafenib #Tosylate_Tablets

Kexing Biopharm Achieves FDA DMF Registration for Advancing Stem Cell-Derived Exosome Research Kexing Biopharm has successfully registered its Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes with the FDA, paving the way for innovative medical applications.

Kexing Biopharm Achieves FDA DMF Registration for Advancing Stem Cell-Derived Exosome Research #FDA_Registration #Exosomes #Kexing_Biopharm

BioDlink's Bevacizumab Launch in Colombia and Pakistan Marks New Era in Oncology Treatments BioDlink accelerates its global growth with successful bevacizumab launches in Colombia and Pakistan, striving to enhance oncology treatment access.

BioDlink's Bevacizumab Launch in Colombia and Pakistan Marks New Era in Oncology Treatments #China #Suzhou #Kexing_Biopharm #BioDlink #Bevacizumab

Kexing Biopharm Forms Strategic Partnership with IQVIA for Global Expansion Efforts Kexing Biopharm has partnered with IQVIA to advance clinical development and commercialization of innovative drugs globally, emphasizing European and regulated markets.

Kexing Biopharm Forms Strategic Partnership with IQVIA for Global Expansion Efforts #China #Shenzhen #biopharmaceuticals #Kexing_Biopharm #IQVIA

Kexing Biopharm and IQVIA Unite to Propel Global Pharma Expansion Kexing Biopharm has formed a strategic partnership with IQVIA to enhance its global expansion in the pharmaceutical industry, focusing on clinical development and market access.

Kexing Biopharm and IQVIA Unite to Propel Global Pharma Expansion #China #Shenzhen #biopharmaceuticals #Kexing_Biopharm #IQVIA

Kexing Biopharm and IQVIA Form Strategic Alliance to Enhance Global Expansion Efforts Kexing Biopharm partners with IQVIA to bolster its global reach in clinical development and commercialization, focusing on regulated markets.

Kexing Biopharm and IQVIA Form Strategic Alliance to Enhance Global Expansion Efforts #China #Shenzhen #Global_Expansion #Kexing_Biopharm #IQVIA

Kexing Biopharm and IQVIA Team Up for Global Expansion in Healthcare Kexing Biopharm has partnered with IQVIA to boost its global reach in clinical development, regulatory approval, and commercialization of innovative drugs.

Kexing Biopharm and IQVIA Team Up for Global Expansion in Healthcare #China #Shenzhen #Global_Expansion #Kexing_Biopharm #IQVIA

BioDlink Achieves Significant GMP Certification Milestone in Argentina for Global Expansion BioDlink Biopharm has obtained GMP certification from Argentina, enhancing its global presence and commitment to oncological therapies with Pusintin® injection.

BioDlink Achieves Significant GMP Certification Milestone in Argentina for Global Expansion #Suzhou #Argentina #Kexing_Biopharm #BioDlink #Pusintin

Kexing Biopharm's GB18 Project Gains IND Approval from NMPA and FDA Kexing Biopharm celebrates a major milestone as their GB18 project receives Investigational New Drug approval from both NMPA and FDA.

Kexing Biopharm's GB18 Project Gains IND Approval from NMPA and FDA #China #Shenzhen #Kexing_Biopharm #GB18 #IND_approval

Kexing Biopharm Secures IND Approval for Innovative GB05 in the U.S. Kexing Biopharm's GB05, an inhalation treatment for RSV, receives IND approval from the FDA, paving the way for clinical trials in the U.S.

Kexing Biopharm Secures IND Approval for Innovative GB05 in the U.S. #China #Shenzhen #Kexing_Biopharm #GB05 #RSV_Treatment